NewAmsterdam Pharma Company NV (NAMS)

Sector:
FINANCE
Industry:
CORPORATE FINANCE
CEO:
Michael H. Davidson
Employees:
4

View recent insider trading info

NewAmsterdam Pharma Company NV YCharts
Yahoo! Finance finviz

Funds Holding NAMS (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding NAMS

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

BIGHAM MICHAEL

  • Director
 0 2022-11-22 1

GALLAGHER CAROL GILTNER

  • Director
 0 2022-11-22 1

BALTERA ROBERT JR.

  • Director
 0 2022-11-22 1

POLU KRISHNA R

  • Director
 0 2022-11-22 1

TOPPER DAVID JOSEPH CHIEF FINANCIAL OFFICER

  • Officer
  • Director
 0 2022-11-22 1

TOPPER JAMES N CHIEF EXECUTIVE OFFICER

FRAZIER LIFESCIENCES SPONSOR LLC

FRAZIER LIFE SCIENCES X, L.P.

FHMLS X, L.P.

FHMLS X, L.L.C.

HERON PATRICK J

  • Officer
  • Director
  • 10% Owner
 2,001,333 2020-12-11 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
NEWAMSTERDAM PHARMA CO NV NAMS 2023-09-29 22:15:03 UTC -128.5843 133.9043 4000
NEWAMSTERDAM PHARMA CO NV NAMS 2023-09-29 21:45:04 UTC -128.5843 133.9043 4000
NEWAMSTERDAM PHARMA CO NV NAMS 2023-09-29 21:15:03 UTC -128.5843 133.9043 4000
NEWAMSTERDAM PHARMA CO NV NAMS 2023-09-29 20:45:05 UTC -128.5843 133.9043 4000
NEWAMSTERDAM PHARMA CO NV NAMS 2023-09-29 20:15:04 UTC -128.5843 133.9043 4000
NEWAMSTERDAM PHARMA CO NV NAMS 2023-09-29 19:45:04 UTC -128.5843 133.9043 4000
NEWAMSTERDAM PHARMA CO NV NAMS 2023-09-29 19:15:03 UTC 0.0 0.0 4000
NEWAMSTERDAM PHARMA CO NV NAMS 2023-09-29 18:45:03 UTC 0.0 0.0 4000
NEWAMSTERDAM PHARMA CO NV NAMS 2023-09-29 18:15:03 UTC 0.0 0.0 4000
NEWAMSTERDAM PHARMA CO NV NAMS 2023-09-29 17:45:03 UTC 0.0 0.0 4000
NEWAMSTERDAM PHARMA CO NV NAMS 2023-09-29 17:15:04 UTC 0.0 0.0 4000
NEWAMSTERDAM PHARMA CO NV NAMS 2023-09-29 16:45:04 UTC -128.5843 133.9043 4000
NEWAMSTERDAM PHARMA CO NV NAMS 2023-09-29 16:15:03 UTC -128.5843 133.9043 4000
NEWAMSTERDAM PHARMA CO NV NAMS 2023-09-29 15:45:04 UTC -128.5843 133.9043 3000
NEWAMSTERDAM PHARMA CO NV NAMS 2023-09-29 15:15:04 UTC -128.5843 133.9043 3000
NEWAMSTERDAM PHARMA CO NV NAMS 2023-09-29 14:45:04 UTC -128.5843 133.9043 3000
NEWAMSTERDAM PHARMA CO NV NAMS 2023-09-29 14:15:04 UTC -128.5843 133.9043 3000
NEWAMSTERDAM PHARMA CO NV NAMS 2023-09-29 13:45:03 UTC -130.4941 135.8141 3000
NEWAMSTERDAM PHARMA CO NV NAMS 2023-09-29 13:15:04 UTC -130.4941 135.8141 3000
NEWAMSTERDAM PHARMA CO NV NAMS 2023-09-29 12:45:05 UTC -130.4941 135.8141 6000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

No recent transactions

*** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

WhaleWisdom Logo

Elevate your investments